{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:08:15Z","timestamp":1768453695713,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.3816\/cgc.2007.n.021","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T21:11:35Z","timestamp":1221081095000},"page":"386-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Long-Term Follow-up of Intravesical Bacillus Calmette-Gu\u00e9rin Treatment for Superficial Transitional-Cell Carcinoma of the Bladder Involving the Prostatic Urethra"],"prefix":"10.3816","volume":"5","author":[{"given":"Jonathan Harris","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Schellhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CGC.2007.n.021_bib1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0090-4295(89)90314-2","article-title":"Conservative treatment of superficial transitional cell carcinoma of prostatic urethra with intravesical BCG","volume":"34","author":"Orihuela","year":"1989","journal-title":"Urology"},{"key":"10.3816\/CGC.2007.n.021_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0090-4295(03)00134-1","article-title":"Urinary interleukin-8 levels are elevated in subjects with transitional cell carcinoma","volume":"62","author":"Sheryka","year":"2003","journal-title":"Urology"},{"key":"10.3816\/CGC.2007.n.021_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0022-5347(17)58039-8","article-title":"Prostatic involvment by transitional cell carcinoma: pathogenesis, patterns and prognosis","volume":"118","author":"Schellhammer","year":"1977","journal-title":"J Urol"},{"key":"10.3816\/CGC.2007.n.021_bib4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.eururo.2003.12.002","article-title":"TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years","volume":"45","author":"Serretta","year":"2004","journal-title":"Eur Urol"},{"key":"10.3816\/CGC.2007.n.021_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005392-199501000-00020","article-title":"Intravesical BCG treatment for superficial transitional cell carcinoma of the bladder and prostatic urethra","volume":"153","author":"Schellhammer","year":"1995","journal-title":"J Urol"},{"key":"10.3816\/CGC.2007.n.021_bib6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0090-4295(99)80481-6","article-title":"In situ transitional cell carcinoma involvement of prostatic urethra: Bacillus Calmette-Guerin therapy without previous transurethral resection of the prostate","volume":"47","author":"Palou","year":"1996","journal-title":"Urology"},{"key":"10.3816\/CGC.2007.n.021_bib7","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0022-5347(17)37452-9","article-title":"Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup","volume":"147","author":"Herr","year":"1992","journal-title":"J Urol"},{"key":"10.3816\/CGC.2007.n.021_bib8","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0022-5347(05)66518-4","article-title":"The limits of Bacillus Calmette-Guerin for carcinoma in situ of the bladder","volume":"165","author":"Kim","year":"2001","journal-title":"J Urol"},{"key":"10.3816\/CGC.2007.n.021_bib9","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical Bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.3816\/CGC.2007.n.021_bib10","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0022-5347(05)65157-9","article-title":"Contemporary management of stage T1 transitional cell carcinoma of the bladder","volume":"167","author":"Soloway","year":"2002","journal-title":"J Urol"},{"key":"10.3816\/CGC.2007.n.021_bib11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0022-5347(01)69072-4","article-title":"Superficial bladder carcinoma treated with Bacillus Calmette-Guerin: progression-free and disease-specific survival with minimal 10-year follow up","volume":"167","author":"Davis","year":"2002","journal-title":"J Urol"},{"key":"10.3816\/CGC.2007.n.021_bib12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1464-410X.1993.tb16260.x","article-title":"Intravesical Bacillus Calmette-Guerin with the Danish strain for treatment of carcinoma in situ of the bladder","volume":"72","author":"Ovesen","year":"1993","journal-title":"Br J Urol"},{"key":"10.3816\/CGC.2007.n.021_bib13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0022-5347(17)42389-5","article-title":"Superficial transitional cell carcinoma of the bladder associated with mucosal involvment of the prostatic urethra: results of treatment with intravesical Bacillus Calmette-Guerin","volume":"139","author":"Hillyard","year":"1988","journal-title":"J Urol"},{"key":"10.3816\/CGC.2007.n.021_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1464-410X.2003.04274.x","article-title":"Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer","volume":"92","author":"Stein","year":"2003","journal-title":"BJU Int"},{"key":"10.3816\/CGC.2007.n.021_bib15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0090-4295(96)00507-9","article-title":"Incidence of granulomatous prostatitis and acid-fast bacilli after intravesical BCG therapy","volume":"49","author":"LaFontaine","year":"1997","journal-title":"Urology"},{"key":"10.3816\/CGC.2007.n.021_bib16","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1586\/14737140.3.6.809","article-title":"Combined bacillus Calmette-Guerin and interferon use in superficial bladder cancer","volume":"3","author":"O'Donnell","year":"2003","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.3816\/CGC.2007.n.021_bib17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ijc.11352","article-title":"Urinary IL-2 assay for monitoring intravesical bacillus Calmette-Guerin response of superficial bladder cancer during induction course and maintenance therapy","volume":"107","author":"Saint","year":"2003","journal-title":"Int J Cancer"},{"issue":"3","key":"10.3816\/CGC.2007.n.021_bib18","first-page":"CD003231","article-title":"Intravesical Bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer","author":"Shelley","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.3816\/CGC.2007.n.021_bib19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"10.3816\/CGC.2007.n.021_bib20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0022-5347(17)41031-7","article-title":"Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra","volume":"141","author":"Bretton","year":"1989","journal-title":"J Urol"},{"key":"10.3816\/CGC.2007.n.021_bib21","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0022-5347(01)65675-1","article-title":"Editorial: a new staging system for transitional cell carcinoma involvement of the prostate and reconfirmation studies of intravesical therapy for superficial bladder cancer","volume":"156","author":"Hudson","year":"1996","journal-title":"J Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767311701069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767311701069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:21:03Z","timestamp":1761564063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767311701069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1558767311701069"],"URL":"https:\/\/doi.org\/10.3816\/cgc.2007.n.021","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Follow-up of Intravesical Bacillus Calmette-Gu\u00e9rin Treatment for Superficial Transitional-Cell Carcinoma of the Bladder Involving the Prostatic Urethra","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CGC.2007.n.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}